Eclipse 2l
Payments companies reported to CMS as associated with Eclipse 2l. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Eclipse 2l, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Eclipse 2l
These are the largest totals companies reported as associated with Eclipse 2l. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Clemens Schirmer | Danville, PA | Neurological Surgery | $6,266.40 |
| John Andrew Cox | Mobile, AL | Neurocritical Care | $1,490.06 |
| Neil Suryadevara | Pittsburgh, PA | Vascular Neurology | $1,160.27 |
| H Lipshutz | Portland, OR | Diagnostic Radiology | $1,032.27 |
| Thymur Chaudhry | Sacramento, CA | Neuroradiology | $925.96 |
| Isaac Abecassis | Miami, FL | Neurological Surgery | $894.71 |
| Ramesh Grandhi | Salt Lake City, UT | Neurological Surgery | $822.80 |
| John Hawkins | Lincoln, NE | Neurological Surgery | $789.12 |
| Leonardo Brasiliense | Boise, ID | Neurological Surgery | $480.21 |
| Daniel Raper | San Francisco, CA | Neurological Surgery | $442.96 |
Prescribed Eclipse 2l?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.